Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

Cancer treatments can exert cardiotoxic effects, but screening and monitoring can detect and minimize cancer therapy-related cardiotoxicity.

India faces a rapidly escalating triple syndemic of obesity, type 2 diabetes (T2D), and atherogenic dyslipidemia, conditions ...

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a “polypill” combination of three medications typically prescribed for heart failure, once daily for six months, ...

The evolution of heart failure management has transformed from a field questioning its own existence to one requiring complex ...

NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to ...

An earlier blood transfusion—done when hemoglobin levels were higher—after major general or vascular surgery among people with heart disease was associated with a lower risk of some complications but ...

The FDA has granted Fast Track designation to VS-041, an investigational therapy for the treatment of heart failure with preserved ejection fraction.

Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...

An intervention of healthy food deliveries improved quality of life among patients with heart failure after recent ...

Chronic respiratory failure is associated with earlier and greater risks of cardiovascular diseases among individuals with COPD.